Recent Class Action Lawsuit Filed Against Semler Scientific, Inc. by Pomerantz Law Firm

Investor Alert: Semler Scientific, Inc. Faces Class Action Lawsuit

Investors who have suffered losses from their holdings in Semler Scientific, Inc. (NASDAQ: SMLR) should be aware of a recent legal development. The Pomerantz Law Firm has officially announced the filing of a class action lawsuit against the company, seeking accountability for alleged securities fraud that may have impacted many investors.

Background of the Lawsuit

According to the announcement made by Pomerantz LLP, the lawsuit centers around potential illegal business practices and securities manipulation by Semler and certain executives or directors. Investors are encouraged to reach out to the firm to discuss their eligibility to participate in the class action.

Danielle Peyton from Pomerantz LLP emphasized that it is crucial for those who purchased Semler securities during the specified class period to act promptly, as they have until October 28, 2025, to request the Court to appoint them as Lead Plaintiff in this case.

The case arises in light of internal disclosures made by Semler that raise significant concerns. Specifically, in their annual report submitted on February 28, 2025, the company revealed that the U.S. Department of Justice (DOJ) might pursue a complaint related to civil violations of the False Claims Act. This lawsuit would address claims of damages concerning tests carried out using Semler's QuantaFlo device, utilized for diagnosing peripheral artery disease.

Market Reactions

The news of these legal troubles has already started to affect Semler’s stock prices significantly. Following the report on potential legal issues, shares of Semler plummeted by 9.4%, closing at $38.89 on March 3, 2025. Subsequently, when the company announced it had tentatively agreed to pay $29.75 million to settle all claims related to this issue on April 15, 2025, the stock price took another hit, falling by nearly 10%.

These fluctuations in stock price illustrate the immediate impact that legal troubles can have on investor confidence and market performance. Investors are urged to stay informed about developments relating to Semler as more information comes to light.

How to Participate

For those affected and interested in joining the class action, Pomerantz LLP has requested that inquiries be directed to them via email at [email protected] or by calling 646-581-9980. It is recommended that interested parties provide their mailing address, phone number, and the number of shares purchased for a better assessment of their situation.

About Pomerantz LLP

Pomerantz LLP boasts a strong reputation in securities class actions and represents a number of investors seeking justice against corporate misconduct. Founded over 85 years ago by Abraham L. Pomerantz, the firm has a long history of advocating for the rights of investors and class members across various sectors.

Their commitment to clients remains unwavering, and they have successfully recovered significant damages on behalf of those wronged by securities fraud and corporate misconduct. For further details, visit their official website at www.pomerantzlaw.com.

In conclusion, investors feeling the impact of losses related to Semler Scientific, Inc. during this tumultuous period are encouraged to take action now and consider participating in the class action lawsuit.

This lawsuit presents an opportunity for accountability, and affected investors should not miss the approaching deadlines.

_Disclaimer: This article does not constitute legal advice. For specific inquiries related to your investments, consult with a qualified attorney._